Oncology
Cancer clinical trials
Studies of cancers and tumors of every type and site, from prevention to treatment. We’re tracking 20,726 recruiting studies in this area right now.
By phase
- Not applicable9,855
- Phase 24,485
- Phase 12,741
- Phase 1/Phase 21,691
- Phase 31,409
- Phase 2/Phase 3282
- Phase 4263
Top conditions
- Breast Cancer1,232
- Prostate Cancer660
- Cancer656
- Colorectal Cancer499
- Lung Cancer430
- Ovarian Cancer339
- Multiple Myeloma330
- Gastric Cancer301
- Pancreatic Cancer298
- Acute Myeloid Leukemia292
- Hepatocellular Carcinoma285
- Solid Tumor258
- Advanced Solid Tumor254
- Cervical Cancer233
- Head and Neck Cancer229
- Endometrial Cancer206
- Advanced Solid Tumors196
- Esophageal Cancer196
Leading sponsors
- M.D. Anderson Cancer Center452
- Fudan University316
- National Cancer Institute (NCI)290
- Sun Yat-sen University290
- Memorial Sloan Kettering Cancer Center289
- Mayo Clinic237
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences151
- City of Hope Medical Center144
- AstraZeneca132
- University Health Network, Toronto126
Where studies are running
- California1,428
- Texas642
- Arizona515
- Florida444
- Alabama419
- New York411
- Massachusetts341
- Maryland330
- New Jersey267
- Pennsylvania239
Recruiting studies20,726 total
- NCT06152731RecruitingPhase 2
HRD testing for advanced ovarian cancer
This study collects tumor samples from people newly diagnosed with advanced ovarian cancer to test for HRD, a genetic feature that may help doctors predict which treatments work best. The goal is to see if HRD testing can guide future treatment decisions for patients like you.
AmiensAges 18 years+ - NCT06151730Recruiting
Managing blood pressure and heart risks during BTKi treatment
This study looks at how well blood pressure is managed and whether heart problems can be prevented in people with certain blood cancers who are taking a type of targeted therapy called a BTKi. It aims to help you stay healthier during treatment.
Rochester, MinnesotaAges Any age - NCT06152289Recruiting
Better diagnosis with capsule endoscopy images
This trial uses images and videos from routine capsule endoscopy procedures to develop better ways to diagnose conditions. If you're already scheduled for a capsule endoscopy, you can help by allowing your images to be used for research.
ParisAges Any age - NCT06152757RecruitingEarly Phase 1
Cell therapy for advanced gastrointestinal cancers
This trial tests a new type of cell therapy (BGT007H cells) for people with advanced gastrointestinal cancers that have not responded to at least two standard treatments. The therapy uses your own immune cells that are modified to target and attack the cancer.
Zhengzhou, HenanAges 18 years+ - NCT06153147Recruiting
Kidney & blood pressure in childhood cancer survivors
This study looks at kidney health and blood pressure in childhood cancer survivors. If you finished high-risk cancer therapy about 3 years ago, researchers want to see how your kidneys and blood pressure are doing now.
Toronto, OntarioAges Up to 19 years - NCT06153251RecruitingPhase 1
Study of BMS-986453 for Relapsed or Refractory Multiple Myeloma
This study tests a new drug, BMS-986453, for people with multiple myeloma that has come back or stopped responding to previous treatments. The goal is to see if it is safe and works against the cancer.
Birmingham, AlabamaAges 18 years+ - NCT06154291RecruitingPhase 1/Phase 2
XON7 for advanced or metastatic solid tumors
This trial tests an experimental drug called XON7 for people with advanced solid tumors that have not responded to standard treatments. It aims to see if XON7 is safe and effective.
AnderlechtAges 18 years+ - NCT06153667Recruiting
Bearing nsPVA for uterine fibroid embolization (UAE)
This trial tests a new particle material, Bearing nsPVA, for uterine artery embolization (UAE), a procedure that blocks blood flow to fibroids to shrink them and reduce symptoms like heavy bleeding or pain. It aims to see if this material is safe and effective for women with symptomatic fibroids.
Brooklyn, New YorkAges 18 years+ - NCT06153836RecruitingPhase 2
Restoring nipple sensation after mastectomy
This trial is testing a surgical technique to reconnect nerves in the nipple and areola after a mastectomy, aiming to restore feeling. It is for women with breast cancer who are having a nipple-sparing mastectomy with implant reconstruction.
Jacksonville, FloridaAges 18 years+ - NCT06154668Recruiting
Immune cell study in melanoma patients
This study looks at immune cells in your blood to find patterns that might show how well a treatment called anti-PD1 immunotherapy works for melanoma. Your participation could help doctors better understand who benefits from this therapy.
GrenobleAges 18 years+ - NCT06154785Recruiting
Low pressure gas for colorectal surgery (CROSS study)
This trial compares a low, steady gas pressure method (AirSeal) to standard gas pressure during minimally invasive colorectal surgery. The goal is to see if this approach improves recovery and reduces complications.
Jette, Brussels CapitalAges 18 years+ - NCT06155188Recruiting
New transplant method for childhood leukemia
This study tests a new combination of medicines to help donor cord blood cells grow better in children with leukemia after a transplant.
Guangzhou, GuangdongAges 1 month–18 years - NCT06155305Recruiting
Organoid drug test before breast cancer surgery
This trial uses a lab-grown mini-tumor (organoid) from your biopsy to test which chemotherapy drugs work best for your cancer before you have surgery. The goal is to personalize your treatment and improve outcomes.
Hangzhou, ZhejiangAges 18–70 - NCT06155396RecruitingPhase 2
Targeted drug combo for advanced cervical cancer
This trial tests a combination of two drugs: an antibody-drug conjugate (RC48-ADC) that targets HER2 on cancer cells, plus an immunotherapy (Zimberelimab) that helps your immune system attack the cancer. It is for people with advanced cervical cancer whose prior platinum-based chemotherapy has stopped working.
Bengbu, AnhuiAges 18 years+ - NCT06155383RecruitingPhase 2
Surgery and immunotherapy combo for stomach cancer
This trial tests a combination of three drugs (Disitamab Vedotin, Toripalimab, and XELOX) given before and after surgery for gastric or gastroesophageal junction cancer. The goal is to see if this treatment helps shrink the tumor and prevent it from coming back.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06155708Recruiting
Ketone drink study for women with PCOS
This study tests if a special ketone drink can help women with polycystic ovary syndrome (PCOS). Researchers want to see if it improves health markers related to the condition.
Montreal, QuebecAges 18–40 - NCT06156150Recruiting
B7-H4 protein in tumor vaccine for glioma
This study looks at a protein called B7-H4 to help create a potential vaccine for glioma (a type of brain tumor). It uses a small tissue sample taken during your surgery to check if the vaccine might work for you.
Shanghai, Shanghai MunicipalityAges 18–80 - NCT06156410RecruitingPhase 1
Cabozantinib and ifosfamide for relapsed sarcomas
This study tests a combination of two drugs, cabozantinib and ifosfamide, for sarcomas that have come back or not responded to treatment. The goal is to see if this combination can help shrink or control the cancer.
San Francisco, CaliforniaAges 5–40 - NCT06156800Recruiting
Radiation before biopsy in advanced cancer
This trial tests whether it is safe and effective to start radiation therapy before getting a tissue biopsy for patients with advanced or metastatic cancer that needs urgent treatment. It aims to avoid delays in care while still allowing for a biopsy later.
London, OntarioAges 18 years+ - NCT06157151RecruitingPhase 2
New drug plus pembrolizumab for advanced cervical cancer
This trial tests a new experimental drug, PRGN-2009, combined with the immunotherapy pembrolizumab (Keytruda) for people with HPV-related cervical cancer that has come back or spread. It is for those who have already tried pembrolizumab and are looking for another option.
Little Rock, ArkansasAges 18 years+ - NCT06158360Recruiting
Post-surgery symptoms after thyroid cancer surgery
This study looks at how you feel after thyroid surgery for cancer. It tests whether adding Chinese medicine treatments can help with symptoms like pain or fatigue during recovery.
Gyeonggi-doAges 19 years+ - NCT06158139RecruitingPhase 1
Testing modified immune cells for pancreatic cancer
This trial tests a new treatment using your own immune cells (called CAR-T cells) that are modified to target a protein called B7-H3 found on pancreatic cancer cells. The goal is to see if this therapy can help shrink or control the cancer.
Chapel Hill, North CarolinaAges 18 years+ - NCT06157996RecruitingPhase 2
Lenvatinib, Tislelizumab, and CapeOX for advanced stomach cancer
This trial tests a combination of three drugs (lenvatinib, tislelizumab, and CapeOX chemotherapy) as the first treatment for advanced stomach or gastroesophageal junction cancer that is PD-L1 positive and has a low TMEscore. The goal is to see if this combination helps control the cancer better than standard treatments.
Guangzhou, GuangdongAges 18 years+ - NCT06158269RecruitingPhase 2
DVRd treatment for newly diagnosed double-hit myeloma
This trial tests a combination of four drugs (daratumumab, bortezomib, lenalidomide, and dexamethasone) for people newly diagnosed with a high-risk form of multiple myeloma called double-hit myeloma. It aims to see if this drug combo can improve outcomes for those with two or more high-risk genetic changes.
TianjinAges 18–70
Common questions
- How many cancer clinical trials are recruiting?
- Clin2 is tracking 20,726 recruiting oncology studies from the U.S. registry right now, out of 32,091 we cover in this area in total.
- What does “Cancer” cover here?
- Studies of cancers and tumors of every type and site, from prevention to treatment. We group each study into cancer based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a cancer trial near me?
- Use the search to filter cancer studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Skin
- Blood & lymphatic
- Kidney & urinary
- Infections
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.